Mr. Lobo joins Stryker after nearly a decade at Johnson & Johnson, where he held a number of senior-level leadership roles, most recently as worldwide president of Ethicon Endo-Surgery. These moves follow Stryker’s recent closing of the acquisition of Boston Scientific’s neurovascular division. The new group includes Stryker’s neurovascular and spine divisions.
Read the company news release about Mr. Kevin Lobo’s appointment at Stryker.
Related Articles on Device Company Executive Moves:
Klaus Radermacher Joins ConforMIS Scientific Advisory Board
NuOrtho Surgical Appoints Greg Rainey to Board of Directors
Wright Medical Group’s Chief Technology Officer Fired Amid Leadership Shuffle
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.